Research and Development

Showing 15 posts of 9612 posts found.

Clinical research news in brief

August 24, 2011 Research and Development contract research news, research and development news

Private equity firm the Carlyle Group is rumoured to be looking at buying PPD, plus there are updates from CTA/Clininvent, …
quintiles_consulting_troy_norris

Quintiles appoints Troy Norris to head up consulting group

August 24, 2011 Research and Development appointment, research and development

Troy Norris has joined Quintiles as vice president and managing director for the product development and commercialisation practice at its …

UK research receives £800m funding boost

August 23, 2011 Research and Development NIHR, UK research, UK science, research and development news

Research into dementia, cancer, diabetes and heart disease are among the activities to benefit from a new £800 government funding …
GlaxoSmithKline

GSK invests in UK biotech start-up

August 22, 2011 Research and Development Autifony, GSK, biotech, hearing loss, research and development news

GlaxoSmithKline has taken a £1.3 million stake in a new UK biotech spin-out that will develop pharmacological treatments for hearing …

Joint API inspection pilot proves successful

August 17, 2011 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Wainwright Associates

Over recent years compliance with GMP in the manufacture of active substances (APIs) has been the subject of increasing regulatory …

Sanofi Pasteur MSD appoints new UK medical director

August 17, 2011 Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Sanofi Pasteur MSD has appointed Dr Aidrian Kilcoyne as medical director in the UK. He joins the company from Roche …

Contract research news in brief

August 17, 2011 Research and Development research and development news

Our round-up of news from the contract research sector includes the rejection of a cancer drug by the FDA because …

How the best labs manage talent

August 16, 2011 Business Services, Manufacturing and Production, Research and Development careers, recruitment, talent retention

Of the $1.2 trillion spent globally each year on R&D across corporations and academia, 40 per cent – much the …

Onyx Scientific bought by India’s Ipca Labs

August 16, 2011 Manufacturing and Production, Research and Development Ipca, Onyx, contract research news, pharma manufacturing news, research and development news

India’s Ipca Laboratories has bought UK chemistry services firm Onyx Scientific for around £4.6 million ($7.5m). The Mumbai-based company, a …

New head of oncology for Astellas Pharma Europe

August 16, 2011 Research and Development, Sales and Marketing appointment, research and development, sales and marketing

Astellas Pharma has appointed Dr Christopher Thomson as executive director of its new European Oncology Unit.   Dr Thomson will …
GlaxoSmithKline

GSK Parkinson’s drug shows motor skills benefits

August 16, 2011 Research and Development GSK, Impax Pharmaceuticals, Parkinson's disease, research and development news

GlaxoSmithKline’s new drug IPX066 has helped Parkinson’s disease patients retain their motor skills after their medication wore off. IPX066, which …

Afrezza could breathe new life into inhaled insulin market

August 15, 2011 Research and Development, Sales and Marketing diabetes, inhaled insulin, insulin, research and development news

New trials for MannKind’s investigational inhaled insulin drug Afrezza have been given the go-ahead by the FDA, potentially breathing new …

Study shows new genetic risk factors for MS

August 15, 2011 Research and Development genes, multiple sclerosis, research and development news

New genetic links to the immune system have been identified as a possible trigger for multiple sclerosis. The exact causes …

Nanoparticles to target Alzheimer’s disease

August 10, 2011 Research and Development Alzheimer's, nanoparticles

Researchers at Lancaster University funded by the European Union are hoping to develop a new treatment for Alzheimer’s disease. Nanoparticles …

New MS drug shows promise for Abbott

August 10, 2011 Research and Development, Sales and Marketing Abbott, Avonex, Biogen, MS, gilenya

Biogen and Abbott’s multiple sclerosis drug daclizumab has performed well in a mid-stage trial, but two deaths marred the overall …
The Gateway to Local Adoption Series

Latest content